16 September 2026 editorial review · Item
MicroTech Equil patch pump: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: MicroTech Equil patch pump
Scope and findings: Added in the second discovery pass. An established wearable patch pump with bolus calculation, temporary basal and extended boluses. MicroTech’s developing closed-loop program is separate; no approved AID functionality is inferred for this pump. Numerical claims are tied to the cited product specifications or named study, and editorial scores do not represent measured comparative performance.
Primary sources checked:
- MicroTech Equil patch insulin pump specifications
- MicroTech2023 annual report: Equil and AiDEX marketed internationally
- MicroTech June2026 commercial products and developing closed-loop system
Limits: Scope is the specific claims documented in the new record. Local stock, payer rules, every hardware variant and unreported head-to-head outcomes are not verified. Regulatory status, manufacturer marketing and clinical performance are distinct.